Regenx Celebrates Grand Opening, Paving the Way for Green Innovation in PGM Recovery
October 26, 2023 02:00 ET
|
Regenx Tech Corp.
EDMONTON, Alberta, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the “Company” or “Regenx” (CSE:RGX) (OTCQB:RGXTF) (FSE:YRS WKN:A2DSW3) is pleased to announce that the official Grand Opening...
Mydecine Provides Q4 2023 Business Update
October 26, 2023 02:00 ET
|
Mydecine Innovations Group Inc.
Mydecine is pleased to address its shareholders and provide a general update on the company's progress.
Blockmate Ventures to Acquire Lithium Battery Distributor, BESS
October 26, 2023 00:26 ET
|
Blockmate Ventures Inc.
TORONTO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc (TSX.V: MATE) (FSE: 8MH1) ("Blockmate" or “the Company"), is pleased to announce that it has entered into a binding Share Purchase...
Sirona Biochem Announces Change of Auditor
October 25, 2023 18:28 ET
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC:SRBCF) (the “Company") announces that it has changed its auditors from DeVisser...
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
October 25, 2023 17:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
EnWave Signs Research and Development License Agreement with Major Australian University
October 25, 2023 09:00 ET
|
EnWave Corporation
DELTA, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a Research and Development...
Stallion Discoveries Launches Survey Over Largest Uranium Exploration Project in the Southwestern Athabasca Basin
October 25, 2023 08:25 ET
|
Stallion Discoveries
Stallion Discoveries Launches Survey Over Largest Uranium Exploration Project in the Southwestern Athabasca Basin
Recce Pharmaceuticals Announces Safety Committee Approves Faster Infusion Rate in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
October 25, 2023 08:00 ET
|
Recce Pharmaceuticals
Independent Safety Committee approves the next cohort dosing of RECCE® 327 (R327) at a faster infusion rate of 15 minutes of 3,000mg via intravenous (IV) administrationR327 was shown to be safe and...
XORTX Announces Rescheduling of Special Meeting of Shareholders
October 25, 2023 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
Improving the Performance of Anode Materials With Novacium's Patented Surface Treatment Processes
October 25, 2023 07:00 ET
|
HPQ Silicon Inc.
Novacium's surface treatment boosts silicon anode battery performance, addressing degradation and charging time, opening new market opportunities